DIT309
/ Fuzhou Tcelltech Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 07, 2025
Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
(clinicaltrials.gov)
- P1 | N=15 | Not yet recruiting | Sponsor: Tcelltech Inc.
New P1 trial • Oncology • Osteosarcoma • Sarcoma • Soft Tissue Sarcoma • Solid Tumor
1 to 1
Of
1
Go to page
1